Israel Englander Sonoma Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.13 - $0.23 $2,454 - $4,342
-18,881 Reduced 59.19%
13,016 $2,000
Q4 2023

Feb 14, 2024
BUY
$0.14 - $0.77 $4,465 - $24,560
31,897 New
31,897 $5,000
Q1 2023

May 15, 2023
BUY
$0.94 - $2.02 $6,555 - $14,087
6,974 Added 42.01%
23,574 $23,000
Q4 2022

Feb 14, 2023
BUY
$1.01 - $53.8 $16,766 - $893,080
16,600 New
16,600 $19,000

Others Institutions Holding SNOA

# of Institutions
1
Shares Held
2.27K
Call Options Held
0
Put Options Held
0
View Full List

About Sonoma Pharmaceuticals, Inc.

SNOA Quotes by TradingView
  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $8M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email